Search:
Home  About  Submit Site    
  
 
Sunitinib is used as a targeted therapy and a receptor protein-tyrosine kinase inhibitor for advanced renal cell cancer and gastrointensinal stromal tumor (GIST). Sunitinib is marketed under the name Sutent. The drug may also be used in combination with other chemotherapy drugs or for the treatment of other cancers.
This directory is made available through a Creative Commons Attribution license from the DMOZ Organization.

© 2025 - Midnight Design Productions, LLC